Neuroscience
Neurotransmitter receptors function via various G-protein coupled and G-protein independent mechanisms that activate downstream intracellular signaling pathways such as cAMP/PKA, PI3K/AKT, phospholipase A2, and phospholipase C pathways. For instance, dopamine receptors act through adenylate cyclase to activate PKA and other signaling molecules, thereby mediate gene expression through the actions of CREB and other transcription factors. Other neurotransmitters such as NMDAR or AMPAR are associated with ion channels that control flux of Ca2+ and Na+, thus propagating the action potential across the post-synaptic neuron.
Dysfunctions in GABAergic/glutamatergic/serotonergic/dopaminergic pathways result in a broad range of neurological disorders such as chronic pain, neurodegenerative diseases, and insomnia, as well as mental disorders including schizophrenia, bipolar disorder, depression, and addiction.
-
C3098 L-Acetylcarnitine (hydrochloride)Summary: used in targeting cardiovascular pathologies and as an acetylcholine mimic.
-
B5897 ML352Summary: Non-competitive inhibitor of the presynaptic choline transporter
-
C4396 VU0364572 (trifluoroacetate salt)Summary: M1 agonist
-
B4873 NitenpyramSummary: nicotinic acetylcholine receptor (AchR) agonist
-
B4878 LY2119620Summary: positive allosteric modulator of M2/M4 receptor
-
B3415 Solifenacin hydrochlorideSummary: muscarinic receptor antagonist
-
B3433 Flavoxate hydrochlorideSummary: muscarinic AChR antagonist
-
B6393 (±)-Vesamicol hydrochlorideSummary: acetylcholine transport inhibitor